Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ASB | Kitowski Nicole M | Executive Vice President | 15.07.2026 | J | 30,64 | 25 | 766 | Form 4 |
| ASB | Hladio Jayne C | EVP, President Private Wealth | 15.07.2026 | J | 30,64 | 13 | 398 | Form 4 |
| ACR | Eagle Point Credit Management LLC | 10% Owner | 15.07.2026 | Verkauf | 21,85 | 9 | 197 | Form 4 |
| VRSK | Mann Elizabeth | Chief Financial Officer | 15.07.2026 | Verkauf | 192,11 | 400 | 76.844 | Form 4 |
| TLN | Nutt Terry L | President | 15.07.2026 | Steuer-Abgabe | 385,80 | 3.271 | 1.261.952 | Form 4 |
| TLN | Nutt Terry L | President | 15.07.2026 | Optionsausübung | — | 8.312 | — | Form 4 |
| SMHI | Llorca Jesus | EVP & CFO | 15.07.2026 | Verkauf | 8,42 | 13.914 | 117.156 | Form 4 |
| RBBN | Grayson Bruns H | Director | 15.07.2026 | Zuteilung | — | 14.423 | — | Form 4 |
| RBBN | Shani Shaul | Director | 15.07.2026 | Zuteilung | — | 11.752 | — | Form 4 |
| PSNL | Chen Richard | President and CMO | 15.07.2026 | Verkauf | 15,15 | 100.000 | 1.515.000 | Form 4 |
| PSNL | Chen Richard | President and CMO | 15.07.2026 | Optionsausübung | 2,44 | 100.000 | 244.000 | Form 4 |
| PB | Holmes Ned S | Director | 15.07.2026 | Verkauf | 73,11 | 95 | 6.945 | Form 4 |
| PB | Holmes Ned S | Director | 15.07.2026 | Verkauf | 72,15 | 5 | 361 | Form 4 |
| PB | Holmes Ned S | Director | 15.07.2026 | Verkauf | 73,09 | 500 | 36.545 | Form 4 |
| PINS | Rajaram Gokul | Director | 15.07.2026 | Verkauf | 22,85 | 1.050 | 23.993 | Form 4 |
| PINS | Silbermann Benjamin | Director | 15.07.2026 | Verkauf | 23,03 | 46.875 | 1.079.438 | Form 4 |
| PINS | Silbermann Benjamin | Director | 15.07.2026 | Wandlung | — | 46.875 | — | Form 4 |
| ORKA | Goncalves Joana | Chief Medical Officer | 15.07.2026 | Verkauf | 87,25 | 300 | 26.176 | Form 4 |
| ORKA | Goncalves Joana | Chief Medical Officer | 15.07.2026 | Verkauf | 86,68 | 3.803 | 329.630 | Form 4 |
| ORKA | Goncalves Joana | Chief Medical Officer | 15.07.2026 | Verkauf | 85,86 | 2.497 | 214.385 | Form 4 |
| ORKA | Goncalves Joana | Chief Medical Officer | 15.07.2026 | Verkauf | 84,37 | 400 | 33.746 | Form 4 |
| ORKA | Goncalves Joana | Chief Medical Officer | 15.07.2026 | Optionsausübung | 7,80 | 3.500 | 27.300 | Form 4 |
| NUVL | Meyers Michael L. | Director | 15.07.2026 | Abgabe | — | 3.444 | — | Form 4 |
| NUVL | Meyers Michael L. | Director | 15.07.2026 | U | 124,00 | 5.146 | 638.104 | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 15.07.2026 | U | 124,00 | 44.433 | 5.509.692 | Form 4 |
| NUVL | Srivastava Sapna | Director | 15.07.2026 | Abgabe | — | 3.444 | — | Form 4 |
| NUVL | Srivastava Sapna | Director | 15.07.2026 | U | 124,00 | 5.146 | 638.104 | Form 4 |
| NUVL | Oliger Christy J. | Director | 15.07.2026 | Abgabe | — | 6.091 | — | Form 4 |
| NUVL | Oliger Christy J. | Director | 15.07.2026 | U | 124,00 | 1.324 | 164.176 | Form 4 |
| NUVL | Squarer Ron | Director | 15.07.2026 | Abgabe | — | 6.281 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 15.07.2026 | U | 124,00 | 31.530 | 3.909.720 | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 15.07.2026 | U | 124,00 | 17.017 | 2.110.108 | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 15.07.2026 | Abgabe | — | 7.120 | — | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 15.07.2026 | Zuteilung | — | 7.120 | — | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 15.07.2026 | Abgabe | — | 29.433 | — | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 15.07.2026 | U | 124,00 | 21.092 | 2.615.408 | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 15.07.2026 | U | 124,00 | 22.393 | 2.776.732 | Form 4 |
| NUVL | Porter James Richard | President and CEO | 15.07.2026 | Abgabe | — | 40.025 | — | Form 4 |
| NUVL | Porter James Richard | President and CEO | 15.07.2026 | Zuteilung | — | 40.025 | — | Form 4 |
| NUVL | Porter James Richard | President and CEO | 15.07.2026 | Abgabe | — | 121.350 | — | Form 4 |
| NUVL | Porter James Richard | President and CEO | 15.07.2026 | U | 124,00 | 203.529 | 25.237.596 | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 15.07.2026 | U | 124,00 | 18.534 | 2.298.216 | Form 4 |
| NUVL | Protopapas Anna | Director | 15.07.2026 | Abgabe | — | 3.444 | — | Form 4 |
| NUVL | Protopapas Anna | Director | 15.07.2026 | U | 124,00 | 5.146 | 638.104 | Form 4 |
| NUVL | Bogle Grant C. | Director | 15.07.2026 | Abgabe | — | 5.577 | — | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).